In the BioHarmony Drug Report Database

"Preview" Icon

Pindolol

Visken (pindolol) is a small molecule pharmaceutical. Pindolol was first approved as Visken on 1982-09-03. It is used to treat angina pectoris, hypertension, and myocardial infarction in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 1B.

 

Trade Name

 

Visken
 

Common Name

 

pindolol
 

ChEMBL ID

 

CHEMBL500
 

Indication

 

angina pectoris, hypertension, myocardial infarction
 

Drug Class

 

Beta-blockers (propranolol type)

Image (chem structure or protein)

Pindolol structure rendering